Free Trial

CNS Pharmaceuticals (CNSP) Institutional Ownership

CNS Pharmaceuticals logo
$5.01 -0.51 (-9.24%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$5.13 +0.12 (+2.40%)
As of 07:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for CNS Pharmaceuticals (NASDAQ:CNSP)

Current
Institutional Ownership
Percentage
14.02%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$4.33M
Number of
Institutional Sellers
(last 12 months)
0
Get CNSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CNSP Institutional Buying and Selling by Quarter

CNS Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Ikarian Capital LLC45,830$241K0.0%N/A7.392%
2/18/2026Boothbay Fund Management LLC13,524$71K0.0%N/A2.181%
8/14/2025Armistice Capital LLC406,000$335K0.0%N/A90.222%
2/18/2025Connective Capital Management LLC280,055$34K0.0%N/A0.487%
2/17/2025Citadel Advisors LLC321,874$39K0.0%N/A0.560%
2/14/2025Jane Street Group LLC419,737$51K0.0%+1,712.3%0.730%
2/14/2025Integrated Wealth Concepts LLC250,000$30K0.0%N/A0.435%
2/13/2025XTX Topco Ltd294,919$36K0.0%N/A0.513%
2/12/2025Geode Capital Management LLC387,064$47K0.0%+90.5%0.673%
2/7/2025Wealthfront Advisers LLC216,046$26K0.0%N/A0.376%
5/20/2024Virtu Financial LLC94,246$34K0.0%+616.6%0.795%
2/13/2024Armistice Capital LLC122,000$155K0.0%N/A1.965%
1/17/2024Smith Anglin Financial LLC50,000$64K0.0%N/A0.952%
8/7/2023Acadian Asset Management LLC22,292$49K0.0%N/A1.000%
7/12/2023FSM Wealth Advisors LLC16,334$38K0.0%N/A0.732%


CNSP Institutional Ownership - Frequently Asked Questions

During the previous two years, 11 institutional investors and hedge funds held shares of CNS Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($335K), Ikarian Capital LLC ($241K), Boothbay Fund Management LLC ($71K), Jane Street Group LLC ($51K), Geode Capital Management LLC ($47K), Citadel Advisors LLC ($39K), and XTX Topco Ltd ($36K).Learn more on CNS Pharmaceuticals' institutional investors.

14.02% of CNS Pharmaceuticals' stock is owned by institutional investors. Learn more on CNSP's institutional investor holdings.

Of the 11 institutional investors that purchased CNS Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($406K), Jane Street Group LLC ($396.58K), Citadel Advisors LLC ($321.87K), XTX Topco Ltd ($294.92K), Connective Capital Management LLC ($280.06K), Integrated Wealth Concepts LLC ($250K), and Wealthfront Advisers LLC ($216.05K).

Institutional investors have bought a total of 465,354 shares in the last 24 months. This purchase volume represents approximately $4.33M in transactions.



This page (NASDAQ:CNSP) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners